Next Article in Journal
Asthma Control Test to Identify Uncontrolled Asthma in Pediatric Clinical Practice
Previous Article in Journal
Management of Non-COVID Respiratory Illnesses during the COVID-19 Pandemic—A Pulmonologist’s Perspective
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Potential Effects of A Flavonoid, Hesperidin on SARS-CoV-2 Disease

by
Mohammad Reza Reza Khazdair
Pharmaceutical Science and Clinical Physiology, Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
Adv. Respir. Med. 2021, 89(4), 472-473; https://doi.org/10.5603/ARM.a2021.0093
Submission received: 14 January 2021 / Revised: 10 April 2021 / Accepted: 10 April 2021 / Published: 2 September 2021

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The novel coronavirus, COVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in China in December 2019 [...]

Share and Cite

MDPI and ACS Style

Khazdair, M.R.R. Potential Effects of A Flavonoid, Hesperidin on SARS-CoV-2 Disease. Adv. Respir. Med. 2021, 89, 472-473. https://doi.org/10.5603/ARM.a2021.0093

AMA Style

Khazdair MRR. Potential Effects of A Flavonoid, Hesperidin on SARS-CoV-2 Disease. Advances in Respiratory Medicine. 2021; 89(4):472-473. https://doi.org/10.5603/ARM.a2021.0093

Chicago/Turabian Style

Khazdair, Mohammad Reza Reza. 2021. "Potential Effects of A Flavonoid, Hesperidin on SARS-CoV-2 Disease" Advances in Respiratory Medicine 89, no. 4: 472-473. https://doi.org/10.5603/ARM.a2021.0093

Article Metrics

Back to TopTop